ABCL-1011: Comparative Real-World Efficacy and Safety of 4-1BB–Based (Liso-Cel/Tisa-Cel) vs CD28 Construct–Containing (Axi-Cel) CAR T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphomas: A Meta-Analysis

Authors

• Hafiz Muhammad Ehsan Arshad
• Maryam Maqsood, Rochester Regional HealthFollow
• Muhammad Zain Raza
• Musab Maqsood
• Anas Babar
• Omar Abdullah Gill

Department

Internal Medicine

Document Type

Conference Proceeding

Publication Title

Clinical Lymphoma Myeloma and Leukemia

Conference Name

Society of Hematologic Oncology (SOHO) Annual Meeting

Conference Date

2026-09-09 - 2026-09-12

First Page

S935

Last Page

S936

DOI

10.1016/S2152-2650(26)02614-5

Volume

26

Issue

Supplement 1

Publication Date

8-1-2026

Recommended Citation

Arshad, H. M., Maqsood, M., Raza, M. Z., Maqsood, M., Babar, A., & Gill, O. A. (2026). ABCL-1011: Comparative Real-World Efficacy and Safety of 4-1BB–Based (Liso-Cel/Tisa-Cel) vs CD28 Construct–Containing (Axi-Cel) CAR T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphomas: A Meta-Analysis. Clinical Lymphoma Myeloma and Leukemia, 26 (Supplement 1), S935-S936. https://doi.org/10.1016/S2152-2650(26)02614-5